These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 8884244
1. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Calò G, Rizzi A, Bogoni G, Neugebauer V, Salvadori S, Guerrini R, Bianchi C, Regoli D. Eur J Pharmacol; 1996 Sep 05; 311(1):R3-5. PubMed ID: 8884244 [Abstract] [Full Text] [Related]
2. Pharmacological characterization of nociceptin receptor: an in vitro study. Calò G, Rizzi A, Bodin M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D. Can J Physiol Pharmacol; 1997 Jun 05; 75(6):713-8. PubMed ID: 9276153 [Abstract] [Full Text] [Related]
3. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors. Bigoni R, Rizzi A, Rizzi D, Becker JA, Kieffer BL, Simonin F, Regoli D, Calo G. Life Sci; 2000 Dec 01; 68(2):233-9. PubMed ID: 11191640 [Abstract] [Full Text] [Related]
4. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens. Zhang G, Murray TF, Grandy DK. Brain Res; 1997 Oct 24; 772(1-2):102-6. PubMed ID: 9406961 [Abstract] [Full Text] [Related]
5. Determination of activity for nociceptin in the mouse vas deferens. Berzetei-Gurske IP, Schwartz RW, Toll L. Eur J Pharmacol; 1996 Apr 29; 302(1-3):R1-2. PubMed ID: 8791013 [Abstract] [Full Text] [Related]
6. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R, Regoli D, Calo G. Naunyn Schmiedebergs Arch Pharmacol; 2001 May 29; 363(5):551-5. PubMed ID: 11383716 [Abstract] [Full Text] [Related]
10. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens. Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW. Br J Pharmacol; 1991 Oct 29; 104(2):428-32. PubMed ID: 1665735 [Abstract] [Full Text] [Related]
13. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120. Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G. Peptides; 2009 Feb 29; 30(2):248-55. PubMed ID: 18992780 [Abstract] [Full Text] [Related]
14. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. Guerrini R, Calo G, Rizzi A, Bianchi C, Lazarus LH, Salvadori S, Temussi PA, Regoli D. J Med Chem; 1997 Jun 06; 40(12):1789-93. PubMed ID: 9191955 [Abstract] [Full Text] [Related]
15. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D. J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188 [Abstract] [Full Text] [Related]
16. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor. Guerrini R, Caló G, Bigoni R, Rizzi D, Rizzi A, Zucchini M, Varani K, Hashiba E, Lambert DG, Toth G, Borea PA, Salvadori S, Regoli D. J Med Chem; 2001 Nov 08; 44(23):3956-64. PubMed ID: 11689082 [Abstract] [Full Text] [Related]